CellPort Software at Philly Cell and Gene Therapy Conference

CellPort is looking forward to be a part of The Philly Cell & Gene Therapy Conference in King of Prussia from June 27-28. This conference brings together researchers, clinicians, service providers, investors, and entrepreneurs dedicated to advancing cell and gene therapy. CellPort is proud to support this community with a purpose-built management platform that simplifies your workflows and ensures you remain audit-ready—so you can focus on the science.

‍

Join us on Friday, June 27 at 11:45 AM in the Malvern Room for our talk titled "From Bench to Batch: Operational Readiness for ATMPs in the New Regulatory Era", where we’ll discuss the EMA’s 2025 ATMP guidance.

‍

Visit our booth to see CellPort in action and learn how we deliver:

• End-to-end lineage tracking of cells and materials—from donor through final product
• Digital master batch records linking protocols, equipment usage, materials and personnel actions
• Audit-ready, GxP-compliant data capture with time-stamps, e-signatures, and built-in audit trails
• Flexible, scalable workflows designed to evolve with your therapeutic programs

‍

Let’s explore how CellPort can turn complex regulatory requirements into real competitive advantage—see you in King of Prussia!